R1 RCM Inc

R1 RCM — Accretive Health — Q3 2016 Earnings Presentation

16 slides from R1 RCM's earnings presentation, Nov 2, 2016

  1. Slide 1: Q3'16 Financial Results Conference Call

    Q3’16 Financial Results Conference Call November 2, 2016 Exhibit 99.2

  2. Slide 2: Safe Harbor Statement

    ©2013 Accret ive Health Inc. Safe Harbor Statement 2 This presentation contains forward-looking statements, including statements regarding future growth, plans and performance. All forward-looking statements contained in this presentation involve risks and uncertainties. The Company’s actual results

  3. Slide 3: Joe Flanagan, President & Chief Executive Officer

    ©2013 Accret ive Health Inc. 3 Joe Flanagan President & Chief Execut ive Officer

  4. Slide 4: Q3 Highlights

    ©2013 Accret ive Health Inc. Q3 Highlights 4  Significant quarter-over-quarter improvement in top- and bot tom-line results  Formally started onboarding Tranche-1 of Ascension Addit ional Book Minist ries (ABMs) • In process of deploying our proprietary Operat ing System and Technology Suite • Cur

  5. Slide 5: Other Efforts Currently Underway

    ©2013 Accret ive Health Inc. Other Efforts Current ly Underway 5  Comprehensive company re-launch planned for early 2017 • Launch new brand in January 2017 • Relist on a major exchange; re-engage with investor community • Simplified financial report ing  Growth • Substant ial market opportunity; <

  6. Slide 6: Chris Ricaurte, Chief Financial Officer & Treasurer

    ©2013 Accret ive Health Inc. 6 Chris Ricaurte Chief Financial Officer & Treasurer

  7. Slide 7: Non-GAAP Measures

    ©2013 Accret ive Health Inc. Non-GAAP Measures* Gross Cash Generated from Customer Cont ract ing Act ivit ies GAAP revenue plus change in deferred customer billings Net Cash Generated from Customer Cont ract ing Act ivit ies GAAP net income before interest expense, taxes, depreciat ion and amort iza

  8. Slide 8: 3Q'16 vs. 2Q'16 and 3Q'15 Results (non-GAAP)

    ©2013 Accret ive Health Inc. 3Q’16 vs. 2Q’16 and 3Q’15 Results (non-GAAP) 8 ($ in millions) 3Q’16 2Q’16 3Q’15 Key change driver(s) Gross Cash Generat ed $59.7 $38.3 $55.4 • Intermountain renewal , including catchup contribut ion • New Ascension contract • Strong PAS growth Cost of Services $43.6 $41

  9. Slide 9: Additional commentary

    ©2013 Accret ive Health Inc. Addit ional commentary 9  2016 Views • Expect to be at the mid-point of top-line guidance of $200-220 million for 2016  Cash posit ion • Cash (inclusive of restricted cash) of $203.4 million at end of Q3, down $19.8 million sequentially • Transit ion to fixed-fee type

  10. Slide 10: 2020 Outlook: Healthy Growth as new Ascension Business is Onboarded

    ©2013 Accret ive Health Inc. ~90% of low-end currently contracted* 2020 Out look: Healthy Growth as new Ascension Business is Onboarded 10 2016 Expectations $220 $200 2020 Expectations $900 $700 G ro ss C as h G en er at ed fr om C us to m er Co nt ra ct in g A ct iv it ie s ($ M M ) Mid- to high-te

  11. Slide 11: Appendix

    ©2013 Accret ive Health Inc. Appendix 11

  12. Slide 12: Use of Non-GAAP Measures

    ©2013 Accret ive Health Inc. Use of Non-GAAP Measures 12 · In order to provide a more comprehensive understanding of the information used by Accretive Health’s management team in financial and operational decision making, the Company supplements its GAAP consolidated financial statements with certai

  13. Slide 13: Reconciliation of GAAP revenue to non-GAAP Gross Cash Generated

    ©2013 Accret ive Health Inc. Reconciliat ion of GAAP revenue to non-GAAP Gross Cash Generated from Customer Contract ing Act ivit ies 13 ($ in thousands) * fav. - Favorable unfav. – Unfavorable n.m. – Not meaningful Three Months Ended September 30, 2016 vs. 2015 Change Nine Months Ended September 30

  14. Slide 14: Reconciliation of GAAP net income (loss) to non-GAAP Net Cash Generated

    ©2013 Accret ive Health Inc. Reconciliat ion of GAAP net income (loss) to non-GAAP Net Cash Generated from Customer Contract ing Act ivit ies 14 ($ in thousands) * fav. - Favorable unfav. – Unfavorable n.m. – Not Meaningful Three Months Ended September 30, 2016 vs. 2015 Change Nine Months Ended Sept

  15. Slide 15: Share-Based Compensation and D&A Expense within Operating Expenses

    ©2013 Accret ive Health Inc. Share-Based Compensat ion and D&A Expense included within Operat ing Expenses 15 Three Months Ended September 30, Nine Months Ended September 30, 2016 2015 2016 2015 (unaudited) (unaudited) Cost of services $1,281 $3,152 $4,804 $5,756 Selling, general and administrative

  16. Slide 16: Condensed Consolidated non-GAAP Financial Information

    ©2013 Accret ive Health Inc. Condensed Consolidated non-GAAP Financial Informat ion 16 Three Months Ended September 30, Nine Months Ended September 30, 2016 2015 2016 2015 GAAP net services revenue $125,535 $15,842 $486,400 $48,898 Increase/(decrease) in deferred customer billings (65,805) 39,541 (3

Accretive Health — Q3 2016 Earnings Presentation on 6ix